Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
British Journal of Haematology
|
January 17, 2025
CAR T access and outcomes in large B-cell lymphoma according to ethnicity and socioeconomic deprivation in the UK
Diana Dragoi, Samuel Cusworth, Laura Oldham, et al.
Blood
|
May 1, 2007
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
Tanzina Haque, Gwen M Wilkie, Marie M Jones, et al.
American Journal of Hematology
|
March 10, 2025
Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Genetic Features: Relevance of the Genetic Underlying Category. A Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMT
Jordi Esteve, Arnon Nagler, Myriam Labopin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 22, 2024
Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study
Ali Bazarbachi, Myriam Labopin, Nour Moukalled, et al.
Bone Marrow Transplantation
|
August 20, 2024
Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMT
Arnon Nagler, Myriam Labopin, Urpu Salmenniemi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 25, 2019
Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus-uninfected Individuals in HPTN 077
Raphael J Landovitz, Sahar Z Zangeneh, Gordon Chau, et al.
Bone Marrow Transplantation
|
June 19, 2025
Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AML
Guillaume Dachy, Myriam Labopin, Gérard Socié, et al.
American Journal of Hematology
|
June 10, 2024
Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide versus conventional anti-graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Arnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Bone Marrow Transplantation
|
December 24, 2025
The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations
Iman Abou Dalle, Jacques-Emmanuel Galimard, Xavier Poire, et al.
American Journal of Hematology
|
April 24, 2024
Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Yishan Ye, Myriam Labopin, Socié Gérard, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
British Journal of Haematology
|
January 17, 2025
CAR T access and outcomes in large B-cell lymphoma according to ethnicity and socioeconomic deprivation in the UK
Diana Dragoi, Samuel Cusworth, Laura Oldham, et al.
Blood
|
May 1, 2007
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
Tanzina Haque, Gwen M Wilkie, Marie M Jones, et al.
American Journal of Hematology
|
March 10, 2025
Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Genetic Features: Relevance of the Genetic Underlying Category. A Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMT
Jordi Esteve, Arnon Nagler, Myriam Labopin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 22, 2024
Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study
Ali Bazarbachi, Myriam Labopin, Nour Moukalled, et al.
Bone Marrow Transplantation
|
August 20, 2024
Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMT
Arnon Nagler, Myriam Labopin, Urpu Salmenniemi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 25, 2019
Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus-uninfected Individuals in HPTN 077
Raphael J Landovitz, Sahar Z Zangeneh, Gordon Chau, et al.
Bone Marrow Transplantation
|
June 19, 2025
Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AML
Guillaume Dachy, Myriam Labopin, Gérard Socié, et al.
American Journal of Hematology
|
June 10, 2024
Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide versus conventional anti-graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Arnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Bone Marrow Transplantation
|
December 24, 2025
The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations
Iman Abou Dalle, Jacques-Emmanuel Galimard, Xavier Poire, et al.
American Journal of Hematology
|
April 24, 2024
Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Yishan Ye, Myriam Labopin, Socié Gérard, et al.
Page
of 11